Disease activity at baseline, was higher in ADA positive patients in our study, which contrasts to what was described by Wincup et al. [15], probably reflecting the fact that our cohort was more skewed towards a higher prevalence of severe lupus manifestations including active nephritis and CNS patients. The gene discussed is ADA; the disease is nephritis.